Abstract
Noncompliance with study medications is an important issue in the design of endpoint clinical trials. Including noncompliant patient data in an intention-to-treat analysis could seriously decrease study power. Standard methods for calculating sample size account for noncompliance, but all assume that noncompliance is noninformative, i.e., that the risk of discontinuation is independent of the risk of experiencing a study endpoint. Using data from several published clinical trials (OPTIMAAL, LIFE, RENAAL, SOLVD-Prevention and SOLVD-Treatment), we demonstrate that this assumption is often untrue, and we discuss the effect of informative noncompliance on power and sample size.
References
Feb 15, 1992·BMJ : British Medical Journal
Sep 3, 1992·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJ N Cohn
Jan 30, 1992·Statistics in Medicine·E Lakatos, K K Lan
Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Aug 1, 1990·The American Journal of Cardiology
Jul 13, 1985·British Medical Journal
Sep 1, 1986·Controlled Clinical Trials·E Lakatos
Jan 1, 1968·Journal of Chronic Diseases·M HalperinF Ederer
Apr 1, 1982·Statistics in Medicine·L S Freedman
Sep 1, 1980·Controlled Clinical Trials·M WuD DeMets
May 24, 2000·Controlled Clinical Trials·J M Lachin
Aug 24, 2000·Epidemiology·J M RobinsB Brumback
Oct 21, 2000·Controlled Clinical Trials·G W Comstock
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Apr 9, 2002·Lancet·Björn DahlöfUNKNOWN LIFE Study Group
Sep 21, 2002·Lancet·Kenneth DicksteinUNKNOWN OPTIMAAL Steering Committee of the OPTIMAAL Study Group
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
May 24, 2003·Biometrics·T Loeys, E Goetghebeur
Dec 4, 2003·Statistics in Medicine·Meinhard Kieser, Tim Friede
Sep 2, 2004·Biometrics·Qi JiangBoris Iglewicz
Citations
Apr 9, 2015·Pharmaceutical Statistics·Yumi KuboGlenn M Chertow
Sep 2, 2004·Biometrics·Qi JiangBoris Iglewicz
Aug 28, 2016·BMC Medical Research Methodology·Alexander PateUNKNOWN GetReal Work Package 2
Oct 25, 2006·Clinical Trials : Journal of the Society for Clinical Trials·Bingbing Li, Patricia Grambsch
Oct 27, 2017·Trials·Susanna DoddPaula Williamson
Sep 1, 2017·Journal of Biopharmaceutical Statistics·Richard F Potthoff
Sep 4, 2015·BMC Research Notes·Temitope E AdewuyiJonathan A Cook
Oct 5, 2018·JAMA : the Journal of the American Medical Association·Sherman Gu